Daihan Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	168,168	171,990	154,056	163,170	183,600	172,200
Market Cap Growth	12.82%	11.64%	-5.59%	-11.13%	6.62%	-12.90%
Enterprise Value	78,646	85,789	80,167	60,093	96,028	117,564
Last Close Price	28600.00	29250.00	25333.88	25919.62	27814.69	25531.67
PE Ratio	6.08	6.22	4.56	5.74	7.36	7.60
PS Ratio	0.81	0.82	0.75	0.83	1.00	1.00
PB Ratio	0.56	0.57	0.56	0.66	0.82	0.85
P/TBV Ratio	0.56	0.57	0.56	0.66	0.82	0.85
P/FCF Ratio	349.24	357.17	7.76	9.28	9.01	5.99
P/OCF Ratio	6.57	6.72	4.32	4.20	6.33	4.24
EV/Sales Ratio	0.38	0.41	0.39	0.31	0.52	0.69
EV/EBITDA Ratio	1.95	2.12	1.77	1.35	2.28	2.90
EV/EBIT Ratio	2.52	2.75	2.11	1.68	2.91	4.04
EV/FCF Ratio	163.33	178.16	4.04	3.42	4.71	4.09
Debt / Equity Ratio	0	0	0	-	0.03	0.12
Debt / EBITDA Ratio	0.00	0.00	0.00	-	0.15	0.58
Debt / FCF Ratio	0.03	0.03	0.00	-	0.32	0.82
Net Debt / Equity Ratio	-0.30	-0.30	-0.28	-0.42	-0.40	-0.36
Net Debt / EBITDA Ratio	-2.22	-2.22	-1.70	-2.35	-2.16	-1.80
Net Debt / FCF Ratio	-185.91	-185.91	-3.89	-5.94	-4.47	-2.53
Asset Turnover	0.62	0.62	0.66	0.69	0.67	0.65
Inventory Turnover	4.75	4.75	5.36	5.38	5.46	5.22
Quick Ratio	2.84	2.84	2.58	3.28	3.04	2.72
Current Ratio	3.64	3.64	3.22	3.87	3.65	3.20
Return on Equity (ROE)	9.59%	9.59%	12.89%	12.01%	11.66%	11.79%
Return on Assets (ROA)	5.80%	5.80%	7.69%	7.83%	7.50%	6.91%
Return on Invested Capital (ROIC)	12.45%	12.70%	17.74%	19.93%	18.62%	15.86%
Return on Capital Employed (ROCE)	10.30%	10.30%	13.50%	14.20%	14.10%	12.80%
Earnings Yield	16.44%	16.07%	21.91%	17.42%	13.59%	13.16%
FCF Yield	0.29%	0.28%	12.88%	10.77%	11.10%	16.71%
Payout Ratio	18.79%	18.79%	12.82%	13.20%	8.45%	9.30%
Buyback Yield / Dilution	-	-	-	1.75%	0.25%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.